Patients' experience and tolerability with canakinumab and anakinra for the treatment of adult-onset Still's disease

被引：0
|
作者：
Campochiaro, C. [1 ,2 ]
Farina, N. [1 ,2 ]
Tomelleri, A. [1 ,2 ]
De Luca, G. [1 ,2 ]
Cavalli, G. [1 ,2 ]
Dagna, L. [1 ,2 ]
机构：
[1] IRCCS San Raffaele Hosp, Unit Immunol Rheumatol Allergy & Rare Dis, Milan, Italy
[2] Univ Vita Salute San Raffaele, Milan, Italy
来源：
CLINICAL AND EXPERIMENTAL RHEUMATOLOGY | 2022年 / 40卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1598 / 1599
页数：2
相关论文
共 50 条
  • [1] Canakinumab for the treatment of adult-onset Still's disease
    Sfriso, Paolo
    Bindoli, Sara
    Doria, Andrea
    Feist, Eugen
    Galozzi, Paola
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2020, 16 (02) : 129 - 138
  • [2] Anakinra in the treatment of adult-onset Still's disease
    Haraoui, B
    Bourrelle, D
    Kaminska, E
    ANNALS OF THE RHEUMATIC DISEASES, 2004, 63 : 293 - 294
  • [3] Anakinra for the treatment of adult-onset Still's disease
    Castaneda, Santos
    Atienza-Mateo, Belen
    Martin-Varillas, Jose L.
    Serra Lopez-Matencio, Jose M.
    Gonzalez-Gay, Miguel A.
    EXPERT REVIEW OF CLINICAL IMMUNOLOGY, 2018, 14 (12) : 979 - 992
  • [4] Efficacy of Canakinumab Treatment in Adult-onset Still's Disease
    Campochiaro, Corrado
    Tomelleri, Alessandro
    Giacomo, De Luca
    Farina, Nicola
    Baldissera, Elena
    Cavalli, Giulio
    Dagna, Lorenzo
    ARTHRITIS & RHEUMATOLOGY, 2019, 71
  • [5] IMPACT OF CANAKINUMAB AND ANAKINRA ON PATIENT-REPORTED OUTCOMES IN ADULT-ONSET STILL'S DISEASE PATIENTS
    Farina, N.
    Campochiaro, C.
    Tomelleri, A.
    De Luca, G.
    Cavalli, G.
    Baldissera, E.
    Dagna, L.
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 : 955 - 956
  • [6] CANAKINUMAB TREATMENT IN ADULT-ONSET STILL'S DISEASE: CASE SERIES
    Ugurlu, S.
    Guzelant, G.
    Yurttas, B.
    Ergezen, B.
    Dalkilic, E.
    Kasifoglu, T.
    Yagiz, B.
    Ozdogan, H.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 514 - 514
  • [7] Canakinumab Treatment in Adult-Onset Still's Disease: Case Series
    Ugurlu, Serdal
    Guzelant, Gul
    Yurttas, Berna
    Ergezen, Bilgesu
    Dalkilic, Ediz
    Kasifoglu, Timucin
    Yagiz, Burcu
    Ozdogan, Huri
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [8] Canakinumab injection for the treatment of active Still's disease, including adult-onset Still's disease
    Tomelleri, Alessandro
    Campochiaro, Corrado
    De Luca, Giacomo
    Farina, Nicola
    Cavalli, Giulio
    Dagna, Lorenzo
    EXPERT OPINION ON ORPHAN DRUGS, 2021, 9 (03): : 77 - 86
  • [9] Effective treatment of steroid refractory adult-onset Still's disease with anakinra
    Maier, Judith
    Birkenfeld, Gabriele
    Pfirstinger, Jochen
    Schoelmerich, Juergen
    Fleck, Martin
    Bruehl, Hilke
    JOURNAL OF RHEUMATOLOGY, 2008, 35 (05) : 939 - 941
  • [10] Anakinra Hepatotoxicity in a Patient With Adult-Onset Still's Disease
    Ahmed, Osman
    Brahmania, Mayur
    Alsahafi, Majid
    Alkhowaiter, Saad
    Erb, Sig
    ACG CASE REPORTS JOURNAL, 2015, 2 (03): : 173 - 174
12345